12 IPOs raised $2.3 billion in the IPO market's busiest week of the year. June 2018 also the set a record as the most active month for IPOs in three years. And as IPO Pro subscribers can see in our newly-released ...read more
Neon Therapeutics, which is developing a targeted immunotherapy platform for various cancers, raised $100 million by offering 6.25 million shares at $16, within the range of $15 to $17. Insiders had indicated on purchasing up to $35 million of the IPO (35%).
...read more
The week ahead will be the busiest week of the year so far for IPO pricings. Getting out ahead of the July slowdown, this record-setting, 12-IPO week is led by two-high growth, high-loss tech companies (Domo and Uxin) and two LBOs (BJ’s and Brightview)....read more
Neon Therapeutics, which is developing a targeted immunotherapy platform for various cancers, announced terms for its IPO on Friday. The Cambridge, MA-based company plans to raise $100 million by offering 6.3 million shares at a price range of $15 to $17....read more
US IPO Weekly Recap: 12 IPOs price in record-setting week, month and quarter
12 IPOs raised $2.3 billion in the IPO market's busiest week of the year. June 2018 also the set a record as the most active month for IPOs in three years. And as IPO Pro subscribers can see in our newly-released ...read more
Immuno-oncology biotech Neon Therapeutics prices IPO at $16 midpoint
Neon Therapeutics, which is developing a targeted immunotherapy platform for various cancers, raised $100 million by offering 6.25 million shares at $16, within the range of $15 to $17. Insiders had indicated on purchasing up to $35 million of the IPO (35%). ...read more
US IPO Week Ahead: 12 IPOs scheduled for the busiest week of the year
The week ahead will be the busiest week of the year so far for IPO pricings. Getting out ahead of the July slowdown, this record-setting, 12-IPO week is led by two-high growth, high-loss tech companies (Domo and Uxin) and two LBOs (BJ’s and Brightview)....read more
Third Rock immuno-oncology biotech Neon Therapeutics sets terms for $100 million IPO
Neon Therapeutics, which is developing a targeted immunotherapy platform for various cancers, announced terms for its IPO on Friday. The Cambridge, MA-based company plans to raise $100 million by offering 6.3 million shares at a price range of $15 to $17....read more